Curasan PRP kit vs. PCCSPRP system - Collection efficiency and platelet counts of two different methods for the preparation of platelet-rich plasma

被引：78

作者：

Weibrich, G ^{[1
]}

Kleis, WKG ^{[1
]}

机构：

[1] Univ Mainz, Clin Oral & Maxillofacial Surg, D-55131 Mainz, Germany

来源：

CLINICAL ORAL IMPLANTS RESEARCH | 2002年 / 13卷 / 04期

关键词：

autologous; buffy coat; growth factor; platelet-rich plasma; thrombocyte concentrate;

D O I：

10.1034/j.1600-0501.2002.130413.x

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

An important reason to improve methods of isolating platelet-rich plasma (PRP) is the potential use of autologous thrombocyte growth factors. In addition to discontinuous cell separation, two methods for extracting PRP that can be performed directly by the surgeon are now available. This study compared the suitability of these two methods for the preparation of PRP Whole blood was drawn from 47 healthy donors (18 men, 29 women) aged 20-59 years (mean 29.9, SD 7.7). For each donor, PRP was separated by the PCCS method (PCCS Kit 3i Implant Innovations, Palm Beach Gardens, FL, USA) and by the Curasan method (analogous to the PRP kit Curasan, Kleinostheim, Germany). Thrombocyte counts differed significantly (sign test P = 0.001) between the donor blood (mean 290,000/mul, SD 86,000/mul), the PCCS PRP preparation (mean 2,209,000/mul, SD 901,000/mul), and the Curasan PRP (mean 1,075,000/mul, SD 636,000/mul). The correlation between the thrombocyte count in the PRP and the thrombocyte count in the donor whole blood was greater for the PCCS PRP (Spearman's correlation coefficient r(s) = 0.60) than for the Curasan PRP (r(s) = 0.34). A slight, clinically irrelevant, influence of gender on thrombocyte concentration in whole blood was found, but no influence of age was detected.

引用

页码：437 / 444

页数：8

共 16 条

[1]

Anitua E., Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants, International Journal of Oral and Maxillofacial Implants, 14, pp. 529-535, (1999)

[2]

Barthelmai W., Isolation of thrombocytes from small blood volumes, Klin Wochenschr, 47, pp. 266-270, (1969)

[3]

Becker W., Lynch S.E., Lekholm U., Becker B.E., Caffesse R., Donath K., Sanchez R., A comparison of ePTFE membranes alone or in combination with platelet-derived growth factors and insulin-like growth factor-I or demineralized freeze-dried bone in promoting bone formation around immediate extraction socket implants, Journal of Periodontology, 63, pp. 929-940, (1992)

[4]

Bland J.M., Altman D.G., Statistical methods for assessing agreement between two methods of clinical measurement, Lancet, 1, pp. 307-310, (1986)

[5]

Cho M.I., Lin W.L., Genco R.J., Platelet-derived growth factor-modulated guided tissue regenerative therapy, Journal of Periodontology, 66, pp. 522-530, (1995)

[6]

Hogman C.F., Eriksson L., Hedlund K., Wallvik J., The bottom and top system: A new technique for blood component preparation and storage, Vox Sanguinis, 55, pp. 211-217, (1988)

[7]

Kiuru J., Viinikka L., Myllyla G., Pesonen K., Perheentupa J., Cytoskeleton-dependent release of human platelet epidermal growth factor, Life Sciences, 49, pp. 1997-2003, (1991)

[8]

Kretschmer V., Biermann E., Loh H., Separation of platelet concentrates (PC) from buffy coat (BC) using the bottom and top drainage (BAT) system, Beitrage Zur Infusionstherapie, 26, pp. 65-70, (1990)

[9]

Lynch S.E., Buser D., Hernandez R.A., Weber H.P., Stich H., Fox C.H., Williams R.C., Effects of the platelet-derived growth factor/insulin-like growth factor-I combination on bone regeneration around titanium dental implants. Results of a pilot study in beagle dogs, Journal of Periodontology, 62, pp. 710-716, (1991)

[10]

Lynch S.E., De Castilla G.R., Williams R.C., Kiritsy C.P., Howell T.H., Reddy M.S., Antoniades H.N., The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing, Journal of Periodontology, 62, pp. 458-467, (1991)

← 1 2 →